This protocol results in a gradual, partial destruction of pancreatic β cells in high fat-fed, insulin-resistant mice without significant effect on islets in chow-fed mice, more closely resembling the features of T2D in humans. The gene discussed is INS; the disease is type 2 diabetes mellitus.